Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03365 | 34027337 | JHEP Rep | Defatting strategies in the current era of liver steatosis. | 2021 | Details |
| A03372 | 34027109 | Clin Exp Hepatol | Non-alcoholic fatty liver disease and lipotoxicity. | 2021 | Details |
| A03375 | 34025683 | Front Immunol | Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD. | 2021 | Details |
| A03376 | 34025577 | Front Endocrinol (Lausanne) | Long Working Hours and Risk of Nonalcoholic Fatty Liver Disease: Korea National Health and Nutrition Examination Survey VII. | 2021 | Details |
| A03377 | 34025131 | J Ginseng Res | Effect of Korean Red Ginseng on metabolic syndrome. | 2020 | Details |
| A03383 | 34022879 | BMC Endocr Disord | The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism. | 2021 | Details |
| A03386 | 34022107 | Liver Int | A Twitter discourse analysis of negative feelings and stigma related to NAFLD, NASH and obesity. | 2021 | Details |
| A03396 | 34017059 | Exp Mol Med | The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease. | 2021 | Details |
| A03397 | 34016882 | J Pediatr Gastroenterol Nutr | Transient Elastography in Pediatric Liver Disease. | 2021 | Details |
| A03400 | 34015596 | Int Immunopharmacol | Interleukin-1 in obesity-related low-grade inflammation: From molecular mechanisms to therapeutic strategies. | 2021 | Details |
| A03410 | 34011624 | BMJ Open Gastroenterol | Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy. | 2021 | Details |
| A03417 | 34007325 | Exp Ther Med | Maternal obesity accelerated non-alcoholic fatty liver disease in offspring mice by reducing autophagy. | 2021 | Details |
| A03419 | 34007127 | World J Gastroenterol | Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect. | 2021 | Details |
| A03420 | 34006994 | Eur J Clin Nutr | Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition? | 2021 | Details |
| A03423 | 34004366 | Ann Hepatol | NAFLD: Challenges and opportunities to address the public health problem in Latin America. | 2021 | Details |
| A03424 | 34004342 | J Nutr Biochem | Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice. | 2021 | Details |
| A03425 | 34004162 | Cell Metab | PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease. | 2021 | Details |
| A03426 | 34004161 | Gastroenterology | Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03430 | 34002452 | Obes Rev | Bariatric surgery and the liver-Mechanisms, benefits, and risks. | 2021 | Details |
| A03432 | 34002097 | Nat Metab | UCP1 governs liver extracellular succinate and inflammatory pathogenesis. | 2021 | Details |
| A03436 | 34001028 | BMC Gastroenterol | Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study. | 2021 | Details |
| A03442 | 33998431 | J Dev Orig Health Dis | Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic de novo lipogenesis in offspring. | 2021 | Details |
| A03445 | 33996858 | Front Med (Lausanne) | De novo Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study. | 2021 | Details |
| A03452 | 33994867 | Int J Biol Sci | MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03453 | 33994854 | Int J Biol Sci | Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver. | 2021 | Details |
| A03456 | 33994069 | Cytokine | Changes in liver steatosis in HIV-positive women are associated with the BMI, but not with biomarkers. | 2021 | Details |
| A03460 | 33992930 | Eur J Med Chem | Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview. | 2021 | Details |
| A03461 | 33992698 | J Hepatol | Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. | 2021 | Details |
| A03463 | 33992352 | Food Res Int | Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice. | 2021 | Details |
| A03464 | 33992322 | Food Res Int | Long-term supplementation with phenolic compounds from jaboticaba (Plinia jaboticaba (Vell.) Berg) reduces adiposophaty and improves glucose, lipid, and energy metabolism. | 2021 | Details |
| A03465 | 33992031 | Semin Liver Dis | Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms. | 2021 | Details |
| A03470 | 33991461 | Physiol Rep | Prevention of non-alcoholic steatohepatitis by long-term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice. | 2021 | Details |
| A03471 | 33991450 | Physiol Rep | Antisense oligonucleotide-mediated knockdown of Mpzl3 attenuates the negative metabolic effects of diet-induced obesity in mice. | 2021 | Details |
| A03475 | 33990287 | J Med Vasc | Subclinical atherosclerosis and arterial stiffness in nonalcoholic fatty liver disease: A case-control study in Algerian population. | 2021 | Details |
| A03484 | 33987424 | Ann Transl Med | Non-alcoholic fatty liver diseases: current challenges and future directions. | 2021 | Details |
| A03492 | 33984335 | Metabolism | Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy. | 2021 | Details |
| A03495 | 33983444 | Nephrol Dial Transplant | Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. | 2022 | Details |
| A03499 | 33982243 | Obes Surg | Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study. | 2021 | Details |
| A03500 | 33982065 | J Clin Endocrinol Metab | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality. | 2021 | Details |
| A03503 | 33979961 | Zhonghua Gan Zang Bing Za Zhi | [Higher proportion of hepatitis B-related hepatocellular carcinoma combined with metabolic diseases in patients receiving antiviral therapy]. | 2021 | Details |
| A03504 | 33978575 | Clin Liver Dis | The Changing Liver Transplant Recipient: From Hepatitis C to Nonalcoholic Steatohepatitis and Alcohol. | 2021 | Details |
| A03505 | 33978572 | Clin Liver Dis | Obesity Management of Liver Transplant Waitlist Candidates and Recipients. | 2020 | Details |
| A03509 | 33977096 | Can J Gastroenterol Hepatol | NAFLD and Infection, a Nuanced Relationship. | 2021 | Details |
| A03511 | 33975804 | Trends Endocrinol Metab | Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A03513 | 33974978 | Free Radic Biol Med | Effects of astaxanthin in animal models of obesity-associated diseases: A systematic review and meta-analysis. | 2021 | Details |
| A03516 | 33973273 | J Gastroenterol Hepatol | Metabolically healthy obesity and risk of non-alcoholic fatty liver disease severity independent of visceral fat. | 2021 | Details |
| A03517 | 33973269 | Hepatology | A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD. | 2021 | Details |
| A03518 | 33973136 | Obes Surg | Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy. | 2021 | Details |
| A03519 | 33972770 | Nat Rev Gastroenterol Hepatol | The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. | 2021 | Details |
| A03520 | 33972568 | Sci Rep | Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. | 2021 | Details |
| A03521 | 33971822 | BMC Gastroenterol | Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. | 2021 | Details |
| A03526 | 33969054 | World J Clin Cases | Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. | 2021 | Details |
| A03527 | 33967948 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population. | 2021 | Details |
| A03529 | 33967554 | World J Gastroenterol | Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. | 2021 | Details |
| A03535 | 33965533 | J Nutr Biochem | Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder. | 2021 | Details |
| A03540 | 33962692 | Microbiome | Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome. | 2021 | Details |
| A03544 | 33961941 | J Hepatol | Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression. | 2021 | Details |
| A03550 | 33960934 | Turk J Gastroenterol | Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03552 | 33960110 | Obes Rev | Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat-A systematic review and meta-analysis. | 2021 | Details |
| A03555 | 33957803 | Exp Biol Med (Maywood) | Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. | 2021 | Details |
| A03564 | 33952843 | Nihon Yakurigaku Zasshi | [The roles of gap junctional intercellular communication in non-alcoholic steatohepatitis (NASH) and liver fibrosis]. | 2021 | Details |
| A03565 | 33952449 | Anticancer Res | Obesity and Liver Cancer in Japan: A Comprehensive Review. | 2021 | Details |
| A03569 | 33951121 | J Gastrointestin Liver Dis | Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan. | 2021 | Details |
| A03570 | 33951119 | J Gastrointestin Liver Dis | The Interrelationship Among Non-Alcoholic Fatty Liver Disease, Colonic Diverticulosis and Metabolic Syndrome. | 2021 | Details |
| A03574 | 33948068 | Ann Gastroenterol | Effectiveness of dietary interventions on cardio-metabolic risk factors in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials. | 2021 | Details |
| A03579 | 33946843 | Microorganisms | Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions. | 2021 | Details |
| A03580 | 33946377 | Medicina (Kaunas) | The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on Covid-19 Disease Prognosis. | 2021 | Details |
| A03581 | 33946154 | Microorganisms | High Rates of Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Metabolic and Cardiovascular Comorbidities. | 2021 | Details |
| A03584 | 33942524 | Pediatr Obes | Association between ectopic pancreatic and hepatic fat and metabolic risk factors in children with non-alcoholic fatty liver disease. | 2021 | Details |
| A03585 | 33941551 | BMJ Open Diabetes Res Care | Insulin resistance and liver histopathology in metabolically unhealthy subjects do not correlate with the hepatic abundance of NLRP3 inflammasome nor circulating IL-1β levels. | 2021 | Details |
| A03592 | 33939147 | Dig Dis Sci | Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03594 | 33938630 | Liver Int | Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis. | 2021 | Details |
| A03602 | 33935810 | Front Physiol | Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03604 | 33935282 | Int J Obes (Lond) | The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. | 2021 | Details |
| A03605 | 33934381 | Hepatology | Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk. | 2021 | Details |
| A03606 | 33933462 | Exp Neurol | Liver inflammation at the time of spinal cord injury enhances intraspinal pathology, liver injury, metabolic syndrome and locomotor deficits. | 2021 | Details |
| A03609 | 33932956 | J Physiol | NAD+ and NAFLD - caution, causality and careful optimism. | 2021 | Details |
| A03621 | 33927697 | Front Endocrinol (Lausanne) | Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy. | 2021 | Details |
| A03623 | 33926085 | Genes (Basel) | The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD. | 2021 | Details |
| A03626 | 33925827 | Int J Mol Sci | Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. | 2021 | Details |
| A03629 | 33924909 | Diagnostics (Basel) | Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome. | 2021 | Details |
| A03630 | 33924725 | Nutrients | The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice. | 2021 | Details |
| A03633 | 33923817 | Int J Mol Sci | Role of Insulin Resistance in MAFLD. | 2021 | Details |
| A03635 | 33923525 | Nutrients | The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. | 2021 | Details |
| A03637 | 33923295 | Int J Mol Sci | Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. | 2021 | Details |
| A03638 | 33923255 | Nutrients | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. | 2021 | Details |
| A03639 | 33923175 | Cells | Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity. | 2021 | Details |
| A03643 | 33922045 | Molecules | Protective Effect of Cudrania tricuspidata Extract against High-Fat Diet Induced Nonalcoholic Fatty Liver Disease through Nrf-2/HO-1 Pathway. | 2021 | Details |
| A03644 | 33921881 | Int J Mol Sci | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. | 2021 | Details |
| A03647 | 33921027 | Int J Mol Sci | Iron at the Interface of Hepatocellular Carcinoma. | 2021 | Details |
| A03648 | 33920792 | J Clin Med | Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes. | 2021 | Details |
| A03651 | 33919415 | Antioxidants (Basel) | Lyophilized Maqui (Aristotelia chilensis) Berry Administration Suppresses High-Fat Diet-Induced Liver Lipogenesis through the Induction of the Nuclear Corepressor SMILE. | 2021 | Details |
| A03652 | 33919190 | Antioxidants (Basel) | The Impact of H2S on Obesity-Associated Metabolic Disturbances. | 2021 | Details |
| A03654 | 33918467 | Biomedicines | Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. | 2021 | Details |
| A03658 | 33917875 | Children (Basel) | Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort. | 2021 | Details |
| A03668 | 33913734 | J Altern Complement Med | Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study. | 2021 | Details |
| A03674 | 33909947 | Mol Nutr Food Res | Effects of Insoluble Cereal Fibre on Body Fat Distribution in the Optimal Fibre Trial. | 2021 | Details |
| A03682 | 33903707 | Sci Rep | MicroRNA Let-7 targets AMPK and impairs hepatic lipid metabolism in offspring of maternal obese pregnancies. | 2021 | Details |
| A03694 | 33900338 | Food Funct | Myricetin improves metabolic outcomes but not cognitive deficit associated to metabolic syndrome in male mice. | 2021 | Details |
| A03696 | 33899670 | Int J Food Sci Nutr | Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension. | 2021 | Details |